Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 1
1987 1
1990 1
1991 2
1992 2
1993 3
1994 3
1995 2
1996 9
1997 4
1998 7
1999 12
2000 5
2001 4
2002 3
2003 5
2004 9
2005 10
2006 11
2007 11
2008 7
2009 6
2010 7
2011 11
2012 12
2013 6
2014 8
2015 7
2016 6
2017 7
2018 6
2019 6
2020 3
2021 4
2022 6
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Results by year

Filters applied: . Clear all
Page 1
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.
Whelan JS, Bielack SS, Marina N, Smeland S, Jovic G, Hook JM, Krailo M, Anninga J, Butterfass-Bahloul T, Böhling T, Calaminus G, Capra M, Deffenbaugh C, Dhooge C, Eriksson M, Flanagan AM, Gelderblom H, Goorin A, Gorlick R, Gosheger G, Grimer RJ, Hall KS, Helmke K, Hogendoorn PC, Jundt G, Kager L, Kuehne T, Lau CC, Letson GD, Meyer J, Meyers PA, Morris C, Mottl H, Nadel H, Nagarajan R, Randall RL, Schomberg P, Schwarz R, Teot LA, Sydes MR, Bernstein M; EURAMOS collaborators. Whelan JS, et al. Among authors: bohling t. Ann Oncol. 2015 Feb;26(2):407-14. doi: 10.1093/annonc/mdu526. Epub 2014 Nov 24. Ann Oncol. 2015. PMID: 25421877 Free PMC article. Clinical Trial.
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Pápai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, Letson GD, Teot LA, Goorin A, Baumhoer D, Kager L, Werner M, Lau CC, Sundby Hall K, Gelderblom H, Meyers P, Gorlick R, Windhager R, Helmke K, Eriksson M, Hoogerbrugge PM, Schomberg P, Tunn PU, Kühne T, Jürgens H, van den Berg H, Böhling T, Picton S, Renard M, Reichardt P, Gerss J, Butterfass-Bahloul T, Morris C, Hogendoorn PC, Seddon B, Calaminus G, Michelagnoli M, Dhooge C, Sydes MR, Bernstein M; EURAMOS-1 investigators. Bielack SS, et al. Among authors: bohling t. J Clin Oncol. 2015 Jul 10;33(20):2279-87. doi: 10.1200/JCO.2014.60.0734. Epub 2015 Jun 1. J Clin Oncol. 2015. PMID: 26033801 Free PMC article. Clinical Trial.
Post-transplant Merkel Cell Carcinoma.
Koljonen V, Sahi H, Böhling T, Mäkisalo H. Koljonen V, et al. Among authors: bohling t. Acta Derm Venereol. 2016 May;96(4):442-7. doi: 10.2340/00015555-2284. Acta Derm Venereol. 2016. PMID: 26554531 Free article. Review.
Prussak's space revisited.
Palva T, Ramsay H, Böhling T. Palva T, et al. Among authors: bohling t. Am J Otol. 1996 Jul;17(4):512-20. Am J Otol. 1996. PMID: 8841695
PDE3A Is a Highly Expressed Therapy Target in Myxoid Liposarcoma.
Toivanen K, Kilpinen S, Ojala K, Merikoski N, Salmikangas S, Sampo M, Böhling T, Sihto H. Toivanen K, et al. Among authors: bohling t. Cancers (Basel). 2023 Nov 7;15(22):5308. doi: 10.3390/cancers15225308. Cancers (Basel). 2023. PMID: 38001568 Free PMC article.
Malignant Eccrine Porocarcinoma in Finland During 2007 to 2017.
Meriläinen AS, Pukkala E, Böhling T, Koljonen V. Meriläinen AS, et al. Among authors: bohling t. Acta Derm Venereol. 2021 Jan 5;101(1):adv00363. doi: 10.2340/00015555-3718. Acta Derm Venereol. 2021. PMID: 33313937 Free PMC article.
191 results